In Bleeding Hemsyl Cvp Tablet helps in controlling bleeding by speeding up blood clotting. It helps to prevent excessive loss of blood, stops bleeding and enhances the healing process. This helps prevent complications of excessive bleeding such as hemorrhage. It should be used as advised by the doctor.
It is unsafe to consume alcohol with Hemsyl Cvp Tablet.
Hemsyl Cvp Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Information regarding the use of Hemsyl Cvp Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Hemsyl Cvp Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Hemsyl Cvp Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Hemsyl Cvp Tablet may not be needed in these patients. Please consult your doctor.
Hemsyl Cvp Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Hemsyl Cvp Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Hemsyl Cvp Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More